Methadone maintenance and narcotic blocking drugs.
Drugs which specifically antagonize certain of the actions of opioids are reviewed. These antagonists include nalorphine, levallorphan, naloxone, naltrexone, and cyclazocine. Programs involving antagonist treatment are discussed.
D000359:Aftercare; D003496:Cyclazocine / Q000627:therapeutic use; D005108:Extinction, Psychological; D006556:Heroin Dependence / Q000534:rehabilitation*; D006760:Hospitalization; D006801:Humans; D007977:Levallorphan / Q000627:therapeutic use; D008691:Methadone / Q000627:therapeutic use*; D009269:Nalorphine / Q000627:therapeutic use; D009270:Naloxone / Q000627:therapeutic use; D009271:Naltrexone / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D011613:Psychotherapy; D011957:Receptors, Opioid / Q000187:drug effects
D009292:Narcotic Antagonists; D011957:Receptors, Opioid; D007977:Levallorphan; D009270:Naloxone; D009271:Naltrexone; D003496:Cyclazocine; D009269:Nalorphine; D008691:Methadone